APA

Kanekiyo S., Takeda S., Nakajima M., Nishiyama M., Kitahara M., Shindou Y., Michihisa I., Abe T., Yoshino S., Hazama S. & Nagano H. (20160830). Efficacy and Safety of Biweekly Docetaxel in Combination with Nedaplatin as Second-line Chemotherapy for Unresectable or Recurrent Esophageal Cancer. : Anticancer research.

Chicago

Kanekiyo Shinsuke, Takeda Shigeru, Nakajima Masao, Nishiyama Mitsuo, Kitahara Masahiro, Shindou Yoshitaro, Michihisa Iida, Abe Toshihiro, Yoshino Shigefumi, Hazama Shoichi and Nagano Hiroaki. 20160830. Efficacy and Safety of Biweekly Docetaxel in Combination with Nedaplatin as Second-line Chemotherapy for Unresectable or Recurrent Esophageal Cancer. : Anticancer research.

Harvard

Kanekiyo S., Takeda S., Nakajima M., Nishiyama M., Kitahara M., Shindou Y., Michihisa I., Abe T., Yoshino S., Hazama S. and Nagano H. (20160830). Efficacy and Safety of Biweekly Docetaxel in Combination with Nedaplatin as Second-line Chemotherapy for Unresectable or Recurrent Esophageal Cancer. : Anticancer research.

MLA

Kanekiyo Shinsuke, Takeda Shigeru, Nakajima Masao, Nishiyama Mitsuo, Kitahara Masahiro, Shindou Yoshitaro, Michihisa Iida, Abe Toshihiro, Yoshino Shigefumi, Hazama Shoichi and Nagano Hiroaki. Efficacy and Safety of Biweekly Docetaxel in Combination with Nedaplatin as Second-line Chemotherapy for Unresectable or Recurrent Esophageal Cancer. : Anticancer research. 20160830.